Business Context and Reporting Period
Company: Entegris, Inc.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended August 26, 2000
Business Overview: Entegris is a leading provider of materials management solutions for the semiconductor and data storage industries. The company protects and transports critical materials (wafers, chemicals) used in microelectronics manufacturing. The fiscal 2000 results reflect a sustained recovery in the semiconductor industry following downturns in 1998 and 1999.
Key Financial Metrics
| Metric (in thousands) | Fiscal 2000 | Fiscal 1999 | Fiscal 1998 |
|---|---|---|---|
| Net Sales | $343,465 | $241,952 | $266,591 |
| Gross Profit | $164,705 | $91,850 | $109,658 |
| Gross Margin | 48.0% | 38.0% | 41.1% |
| Operating Profit | $76,371 | $14,945 | $24,635 |
| Net Income | $50,575 | $5,729 | $13,083 |
| Diluted EPS | $0.77 | $0.09 | $0.21 |
| Cash and Cash Equivalents | $102,973 | $16,411 | $8,235 |
| Long-term Debt | $10,822 | $53,830 | $73,242 |
| Shareholders' Equity | $268,040 | $124,683 | $118,399 |
Liquidity: Operating cash flow was $64.1 million in fiscal 2000. The company holds $103.0 million in cash and has $30.0 million in unsecured revolving credit facilities with no borrowings outstanding domestically.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 42% ($101.5 million) compared to fiscal 1999, driven by a semiconductor industry recovery. Fluid Handling product sales grew 77%, and Microelectronics product sales grew 31%.
- Profitability Expansion: Gross profit increased 79% to $164.7 million. Gross margin improved to 48.0% from 38.0% due to better capacity utilization, favorable product mix, and a $4.3 million reduction in LIFO inventory reserves.
- Debt Reduction: Long-term debt decreased significantly from $53.8 million to $10.8 million. In Q4 2000, the company used $42 million of IPO proceeds to retire long-term debt and capital lease obligations.
- One-Time Items: Fiscal 2000 included a $5.5 million gain on the sale of Metron Technology N.V. shares and a $1.1 million after-tax extraordinary loss on debt extinguishment. Asset impairment charges were $5.9 million (vs. $2.0 million in 1999).
Guidance, Outlook, and Risks
Management Commentary & Outlook:
- Strategy: Focus on expanding technological leadership (specifically 300mm wafer solutions), broadening the product offering, and expanding in Japan and other international markets.
- Capital Allocation: Remaining IPO proceeds ($57 million) are designated for working capital and general corporate purposes. Planned capital expenditures for fiscal 2001 are approximately $35 million.
- Dividends: The company does not intend to pay cash dividends in the foreseeable future.
Risks and Contingencies:
- Industry Cyclicality: The semiconductor industry is highly cyclical; downturns could reduce revenue and profits.
- International Exposure: 48% of sales are international. Risks include currency fluctuations (approx. 25% of sales not in USD) and geopolitical tensions (e.g., China/Taiwan relations).
- Supplier Dependence: Reliance on single or limited-source suppliers for critical polymers could disrupt manufacturing.
- Regulatory: Ongoing cooperation with the U.S. Department of Commerce regarding export licensing practices for valve products sold to Taiwan and Israel (review relates to ~$100,000 in 1999 sales).
- Metron Dependency: 28.3% of revenues are derived through Metron Technology N.V., a distributor in which Entegris holds a 20.3% stake.
Investor Verification Checklist
- Debt Covenants: Verify compliance with new debt agreements signed in fiscal 2000, which require maintaining specific quarterly financial covenants.
- Export Licensing: Monitor the outcome of the Department of Commerce review regarding past export licensing practices to ensure no penalties or future shipment delays.
- 300mm Adoption: Assess market acceptance of the company's 300mm wafer management products, as significant R&D investment is tied to this transition.
- Metron Performance: Review Metron Technology N.V.'s financial health and sales trends, given the significant revenue concentration (28.3%) and equity investment.
- System Integration Costs: Track the $8–10 million projected cost to upgrade and integrate management information systems over the next 2–4 years.